US Patent 7338657 Injectable microspheres for tissue construction
Patent 7338657 was granted and assigned to Biosphere Medical, Inc. on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Egisto Boschetti0
Jean-Marie Vogel0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+403 characters)
Article
Patent abstract
The present invention relates to injectable compositions comprising biocompatible, hydrophilic, non-toxic and substantially spherical microspheres associated with stem cells useful for tissue construction and generation. The invention also relates to methods of tissue construction and generation, for the treatment of various tissue damage and defects, using the injectable compositions.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07338657 Injectable microspheres for tissue construction US Patent 7338657 Injectable microspheres for tissue construction
Infobox
Patent Number
073386570
Patent Number
73386570
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073386570
Date of Patent
March 4, 2008
0Patent Application Number
102209840
Date Filed
March 15, 2001
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07338657 Injectable microspheres for tissue construction
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07338657
Date of patent
March 4, 2008
Patent application number
10220984
Date Filed
March 15, 2001
Patent primary examiner
Find more entities like US Patent 7338657 Injectable microspheres for tissue construction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.